Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,927 | -16,941 | -88,481 | -86,990 | -57,729 |
| Depreciation Amortization | 485 | 243 | 863 | 635 | 416 |
| Income taxes - deferred | N/A | N/A | -367 | N/A | N/A |
| Accounts receivable | -27 | -75 | 186 | 138 | 53 |
| Accounts payable and accrued liabilities | -1,609 | 1,932 | -1,473 | -1,079 | 1,074 |
| Other Working Capital | -13,687 | -9,006 | 9,389 | -3,885 | -722 |
| Other Operating Activity | 9,628 | 3,032 | 1,558 | 19,617 | 9,901 |
| Operating Cash Flow | $-33,137 | $-20,815 | $-78,325 | $-71,564 | $-47,007 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -121 | -135 | -1,309 | -868 | -784 |
| Purchase Of Investment | -35,218 | 0 | -135,675 | -135,675 | -118,513 |
| Sale Of Investment | 51,498 | 16,968 | 183,204 | 175,213 | 125,433 |
| Investing Cash Flow | $16,159 | $16,833 | $46,220 | $38,670 | $6,136 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 26,808 | 26,759 | 26,744 |
| Other Financing Activity | -66 | -55 | -102 | -102 | 0 |
| Financing Cash Flow | $-66 | $-55 | $26,706 | $26,657 | $26,744 |
| Beginning Cash Position | 39,878 | 39,878 | 45,277 | 45,277 | 45,277 |
| End Cash Position | 22,834 | 35,841 | 39,878 | 39,040 | 31,150 |
| Net Cash Flow | $-17,044 | $-4,037 | $-5,399 | $-6,237 | $-14,127 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,137 | -20,815 | -78,325 | -71,564 | -47,007 |
| Capital Expenditure | -121 | -135 | -1,309 | -868 | -784 |
| Free Cash Flow | -33,258 | -20,950 | -79,634 | -72,432 | -47,791 |